Nathalie Lassau

Nathalie Lassau is a leader in radiomics and quantitative imaging biomarkers at Gustave Roussy, one of Europe's premier cancer centers. She has pioneered dynamic contrast-enhanced ultrasound (DCE-US) as a method to quantify tumor perfusion and assess anti-angiogenic therapy response, developing the CEUS response criteria adopted in European trials. Lassau leads large-scale radiomics research programs integrating AI with multi-modal imaging (CT, MRI, PET, ultrasound) and has built one of Europe's largest cancer imaging datasets for AI training. Her research spans imaging-based treatment response prediction, precision monitoring, and AI-augmented radiology workflows.